TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Supportive Medicines Prcourement (Phase 1 Part 2)

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health and Social Care: "Supportive Medicines Prcourement (Phase 1 Part 2)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityDepartment of Health and Social CareScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Department of Health and Social Care
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Department of Health and Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
11.8Bids / Report
54.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 451 active published awards; 397 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDepartment of Health and Social Care
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Mar 2021, 22:44 GMT
Last source update5 Mar 2021, 22:44 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-029914
What is being bought
pharmaceutical products
What changed
From the official release history
  1. Status changed to complete
    5 Mar 2021, 22:44 GMT
  2. Official notice release published
    5 Mar 2021, 22:44 GMT
  3. Buyer information updated
    5 Mar 2021, 22:44 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    A requirement to secure a number ofadditional supportive medicines includingEnd of Life, Intensive Care and Antibioticsfor treatments relating to Covid-19 - urgentdelivery required for available stocks.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Mar 2021, 22:44 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Contract active
    Signed 17 Sept 2020, 00:00 BST · £1
  7. Contract active
    Signed 17 Sept 2020, 00:00 BST · £1
  8. Contract active
    Signed 17 Sept 2020, 00:00 BST · £1
  9. Contract active
    Signed 17 Sept 2020, 00:00 BST · £1
Commercial outcome and competition
Awards
Fresenius Kabi Limited
Not published · Not published · active
Kent Pharma Ltd
Not published · Not published · active
Piramal Critical care Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Contracts
Contract
£1 · signed 17 Sept 2020, 00:00 BST · active
Contract
£1 · signed 17 Sept 2020, 00:00 BST · active
Contract
£1 · signed 17 Sept 2020, 00:00 BST · active
Contract
£1 · signed 17 Sept 2020, 00:00 BST · active
Bid statistics
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
Buyer and organisations in this procedure

Department of Health and Social Care

Contracting authority GB-FTS-43
View buyer profile

  • Department of Health and Social Care
    buyer
    centralPurchasingBody

    39 Victoria Street, London, UKI32, SW1H 0EU
    john.cook@dhsc.gov.uk

  • Accord-UK Ltd
    supplier

    79585
    Whiddon Valley, Barnstaple, UK, EX32 8NS

  • Fresenius Kabi Limited
    supplier

    Runcorn, UK

  • High Court
    mediationBody
    reviewContactPoint

    39 Victoria Street, London, SW1H 0EU

  • Kent Pharma Ltd
    supplier

    Heathrow, UK

  • Piramal Critical care Limited
    supplier

    Uxbridge, UK

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Coronavirus disease (COVID-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020, by this stage Europe was at the centre of the pandemic.During the initial response to the Covid-19 virus (the virus) and due to high global demand, there was concern around the availability of certain medicines used in intensive treatment units and for end of life care (the medicines) and there was a focus on ensuring the medicines would continue to be available to avoid the NHS running out and the impact of this on public health. Although wave 1 of the virus had subsided, the Contracting Authority was expecting and planning for an imminent second wave, and anticipated that the high global demand for the supplies of the medicines would be similar to wave 1. The Contracting Authority, having identified suppliers that were ready, willing and able to supply the medicines, needed to move quickly to secure the available supply. Failure to do this would have resulted in the medicines being sold by the suppliers to another country due to the high global demand. It was imperative to maintain security of supply for public health purposes. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was not feasible in order for the Contracting Authority to secure sufficient supply of the Medicines. The contracts are for the benefit of the Authority and NHS Bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.